The Beijing Reproductive Medicine and Health Conference (CARCE CHINA) will focus on innovations in the fields of male and female infertility, assisted reproductive technology, clinical embryology, reproductive genetics, cross-border endometriosis, adenomyosis, uterine fibroids, and ovarian premature aging regenerative medicine.

By 2025, it is anticipated that the market size for assisted reproduction in China will reach 85.43 billion yuan, with an average annual compound growth rate of 14.5% from 2021 to 2025. Currently, due to uneven distribution and quality of assisted reproductive institutions in China, the need for development of assisted reproductive technology to ensure higher success rates for older patients, and the fact that the top-level design of the assisted reproductive field is still not fully developed, many patients view overseas assisted reproductive technology as their primary choice. Overseas assisted reproduction has become a rapidly evolving global business.

The Chinese Health Association's Reproductive Health Branch and Zhejiang Province's Health Industry Research Association's Reproductive Health Professional Committee are mass organizations composed of reproductive health units and personnel. They are important social forces in promoting and developing China's reproductive health cause. They adhere to the Constitution, laws, regulations, and national policies of our country, vigorously promote and actively facilitate the construction and development of the reproductive health industry; enhance the correct understanding of reproductive health among the general public; strengthen exchanges and cooperation with the reproductive health industries at home and abroad, contributing to the construction of a healthy China in the new era.

Conference attendees include gynecologists, IVF specialists, embryologists, infertility and genetics experts, and agents of their assisted reproductive enterprises. Participants from around the world will attend the Beijing Reproductive Medicine and Health Conference (CARCE CHINA), eager to learn about and discuss the latest global assisted reproductive technologies, solving fertility issues, from patients to agents to reproductive centers, creating miracles of life!